BeOne Medicines Ltd.（ONC）内部人交易：高管与董事近期交易
过去 18 个月，共有 22 位内部人为 BeOne Medicines Ltd.（ONC）报告了 438 笔 Form 4 交易（最近一笔 2026-10-02）。
| 日期 | 内部人 | 职务 | 类型 | 股数 | 市值 |
|---|---|---|---|---|---|
| 2026-10-02 | Lee Chan Henry | SVP, General Counsel | 卖出 | 1,115 | $418,125 |
| 2026-09-30 | Wang Xiaodong | 董事 | 买入 | 31,028 | $1.1M |
| 2026-09-30 | Wang Xiaodong | 董事 | 卖出 | 160 | $57,115 |
| 2026-09-30 | Wang Xiaodong | 董事 | 卖出 | 120 | $43,045 |
| 2026-09-30 | Wang Xiaodong | 董事 | 卖出 | 40 | $14,366 |
| 2026-09-30 | Wang Xiaodong | 董事 | 卖出 | 2,241 | $809,120 |
| 2026-09-30 | Wang Xiaodong | 董事 | 卖出 | 4,239 | $1.5M |
| 2026-09-30 | Wang Xiaodong | 董事 | 卖出 | 3,499 | $1.3M |
| 2026-09-30 | Wang Xiaodong | 董事 | 卖出 | 3,419 | $1.2M |
| 2026-09-30 | Wang Xiaodong | 董事 | 卖出 | 2,047 | $748,891 |
| 2026-09-30 | Wang Xiaodong | 董事 | 卖出 | 14,525 | $5.3M |
| 2026-09-30 | Wang Xiaodong | 董事 | 卖出 | 738 | $271,012 |
| 2026-09-16 | BAKER JULIAN | 董事 | 买入 | 30,768 | $1.1M |
| 2026-09-16 | BAKER FELIX | 董事 | 买入 | 30,768 | $1.1M |
| 2026-09-16 | BAKER BROS. ADVISORS LP | 董事 | 买入 | 30,768 | $1.1M |
| 2026-09-16 | Baker Brothers Life Sciences LP | 董事 | 买入 | 30,768 | $1.1M |
| 2026-09-16 | 667, L.P. | 董事 | 买入 | 30,768 | $1.1M |
| 2026-09-16 | Baker Bros. Advisors (GP) LLC | 董事 | 买入 | 30,768 | $1.1M |
| 2026-09-16 | BAKER JULIAN | 董事 | 买入 | 30,768 | $1.1M |
| 2026-09-16 | BAKER FELIX | 董事 | 买入 | 30,768 | $1.1M |
| 2026-09-16 | BAKER BROS. ADVISORS LP | 董事 | 买入 | 30,768 | $1.1M |
| 2026-09-16 | Baker Brothers Life Sciences LP | 董事 | 买入 | 30,768 | $1.1M |
| 2026-09-16 | 667, L.P. | 董事 | 买入 | 30,768 | $1.1M |
| 2026-09-16 | Baker Bros. Advisors (GP) LLC | 董事 | 买入 | 30,768 | $1.1M |
| 2026-09-10 | Wang Xiaodong | 董事 | 卖出 | 1,181 | $407,897 |
来源：SEC Form 4 申报文件 · 截至 2026-10-02